Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

Autor: Krishna, Rajesh, Anderson, Matt S, Bergman, Arthur J, Jin, Bo, Fallon, Marissa, Cote, Josee, Rosko, Kim, Chavez-Eng, Cynthia, Lutz, Ryan, Bloomfield, Daniel M, Gutierrez, Maria, Doherty, James, Bieberdorf, Fredrick, Chodakewitz, Jeffrey, Gottesdiener, Keith M, Wagner, John A
Zdroj: In The Lancet 2007 370(9603):1907-1914
Databáze: ScienceDirect